Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study
J Harenberg, S Du, M Wehling, S Zolfaghari… - Clinical Chemistry and …, 2016 - degruyter.com
Background: The utility of measuring non-vitamin K antagonist oral anticoagulants (NOACs)
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study
J Harenberg, S Du, M Wehling, S Zolfaghari… - Clin Chem Lab …, 2016 - degruyter.com
Background: The utility of measuring non-vitamin K antagonist oral anticoagulants (NOACs)
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study.
J Harenberg, S Du, M Wehling… - Clinical Chemistry & …, 2016 - search.ebscohost.com
Background: The utility of measuring non-vitamin K antagonist oral anticoagulants (NOACs)
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
[PDF][PDF] Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study
J Harenberg, S Du, M Wehling, S Zolfaghari, C Weiss… - researchgate.net
Background: The utility of measuring non-vitamin K antagonist oral anticoagulants (NOACs)
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study
J Harenberg, S Du, M Wehling… - Clinical chemistry …, 2016 - pubmed.ncbi.nlm.nih.gov
Background The utility of measuring non-vitamin K antagonist oral anticoagulants (NOACs)
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions
J Harenberg, M Wehling, C Weiß, R Krämer - 2016 - katalog.ub.uni-heidelberg.de
Background: The utility of measuring non-vitamin K antagonist oral anticoagulants (NOACs)
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
Measurement of dabigatran, rivaroxaban and apixaban in samples of plasma, serum and urine, under real life conditions. An international study.
J Harenberg, S Du, M Wehling, S Zolfaghari… - Clinical Chemistry …, 2016 - europepmc.org
Background The utility of measuring non-vitamin K antagonist oral anticoagulants (NOACs)
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …
in plasma, serum and urine samples and with the point-of-care test (POCT) on urine …